Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. CGC
stocks logo

CGC

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Intellectia AI SwingMax
Intellectia AI SwingMax

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2026Q3
FY2026Q4
FY2027Q1
70.96M
-5.09%
-0.045
-95.95%
71.78M
+10.38%
-0.040
-97.2%
71.30M
-1.16%
0.000
-100%
Estimates Revision
The market is revising Downward the revenue expectations for Canopy Growth Corporation (CGC) for FY2026, with the revenue forecasts being adjusted by -4.6% over the past three months. During the same period, the stock price has changed by -17.12%.
Revenue Estimates for FY2026
Revise Downward
down Image
-4.6%
In Past 3 Month
EPS Estimates for FY2026
Revise Downward
down Image
-41.14%
In Past 3 Month
Stock Price
Go Down
down Image
-17.12%
In Past 3 Month
Wall Street analysts forecast CGC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CGC is 5.70 USD with a low forecast of 5.70 USD and a high forecast of 5.70 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Analyst Rating
Wall Street analysts forecast CGC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CGC is 5.70 USD with a low forecast of 5.70 USD and a high forecast of 5.70 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 1.210
sliders
Low
5.70
Averages
5.70
High
5.70
Current: 1.210
sliders
Low
5.70
Averages
5.70
High
5.70
Benchmark
Sell -> Hold
upgrade
2025-11-10
Reason
Benchmark
Price Target
2025-11-10
upgrade
Sell -> Hold
Reason
As previously reported, Benchmark upgraded Canopy Growth to Hold from Sell following what the firm calls "another quarter of steady operational improvement." The company ended Q3 with liquidity now "sound," execution improving, and the Canadian core showing sustainable growth, prompting the firm to raise its rating, the analyst tells investors.
Benchmark
Mike Hickey
Sell -> Hold
upgrade
2025-11-10
Reason
Benchmark
Mike Hickey
Price Target
2025-11-10
upgrade
Sell -> Hold
Reason
Benchmark analyst Mike Hickey upgraded Canopy Growth to Hold from Sell.
Zuanic & Associates
Pablo Zuanic
Hold
Initiates
n/a
2025-03-27
Reason
Zuanic & Associates
Pablo Zuanic
Price Target
n/a
2025-03-27
Initiates
Hold
Reason
See All Ratings

Valuation Metrics

The current forward P/E ratio for Canopy Growth Corp (CGC.O) is -6.58, compared to its 5-year average forward P/E of -6.64. For a more detailed relative valuation and DCF analysis to assess Canopy Growth Corp 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-6.64
Current PE
-6.58
Overvalued PE
14.70
Undervalued PE
-27.97

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-263.86
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
467.42
Undervalued EV/EBITDA
-995.13

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
5.98
Current PS
0.00
Overvalued PS
12.67
Undervalued PS
-0.71
Financial AI Agent
Financial AI Agent

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
AI Stock Picker
AI Stock Picker

CGC News & Events

Events Timeline

(ET)
2025-11-07
07:14:20
Canopy Growth announces Q2 earnings per share of 1 cent, falling short of consensus estimate of 11 cents.
select
2025-10-08 (ET)
2025-10-08
07:12:13
Canopy Growth's DOJA Facility in British Columbia Designated as Medical Cultivation Site
select
2025-10-07 (ET)
2025-10-07
08:04:36
Canopy USA and JP Brand Advisors Form Strategic Alliance
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
9.5
11-28NASDAQ.COM
Tilray Brands Enhances Domestic Position with Robust Q1 Cannabis Growth

  • Tilray Brands Performance: Tilray Brands reported a strong fiscal first quarter in 2026, with Canadian cannabis revenues increasing 4% year over year to $51 million, solidifying its position as the largest legal cannabis company in Canada. The company is well-positioned for future growth with significant cultivation capacity and a strong market presence in various product categories.

  • Cresco Labs Operational Results: Cresco Labs experienced steady operational results in the third quarter, maintaining leading market shares in key states. However, the company faced revenue declines due to challenges in the tightly regulated and price-compressed U.S. cannabis market.

  • Canopy Growth's Progress: Canopy Growth showed solid momentum in its Canadian business during the fiscal second quarter, with improvements in both adult-use and medical cannabis segments. The company benefited from stronger sales and operational efficiency, contributing to a more sustainable financial foundation.

  • Stock Performance and Quantum Computing: Tilray Brands' shares have surged 129.1% over the past six months, significantly outperforming the industry. Additionally, there is growing interest in quantum computing, with major tech companies integrating the technology, presenting investment opportunities in this emerging field.

[object Object]
Preview
8.0
11-27TipRanks
Cannabis Stocks Surge as U.S. Medicare Weighs Coverage Options for TLRY, CGC, CRON

  • Medicare Coverage for CBD: U.S. Medicare is considering covering CBD treatments for certain patients, potentially boosting the cannabis industry as shares of leading companies rise by up to 4%.

  • Focus on Cancer and Palliative Care: The initiative primarily targets seniors undergoing cancer treatments or palliative care, marking a significant step for cannabis acceptance in medical settings.

  • Advocacy and Political Support: Payments financier Howard Kessler has engaged with Health and Human Services Secretary Robert F. Kennedy Jr. regarding expanded cannabis access, following previous support from President Trump.

  • Market Performance and Analyst Ratings: Cannabis stocks have struggled recently, with many trading as penny stocks; Tilray, for instance, has a Moderate Buy rating from analysts, suggesting a potential upside of over 92%.

[object Object]
Preview
8.0
11-13SeekingAlpha
Numerous hemp-based THC products at risk of U.S. prohibition following Trump's signing of spending legislation.

  • Impact of Government Spending Bill: Canadian cannabis companies saw a decline in shares after U.S. President Trump signed a spending bill that includes provisions to recriminalize hemp THC products starting in 2026, reversing the legalization established by the 2018 Farm Bill.

  • Details of the New Provisions: The new legislation aims to prevent the unregulated sale of intoxicating hemp-derived products, while still allowing non-intoxicating CBD and industrial hemp products to be sold.

  • Industry Reactions: Tilray, a Canadian cannabis company, criticized the inclusion of hemp-related provisions in the funding bill, calling it misguided and out of touch with consumer interests.

  • Market Developments: The cannabis market is evolving, with non-cannabis companies like Target entering the hemp-derived THC space, indicating growing interest and competition in the sector.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Canopy Growth Corp (CGC) stock price today?

The current price of CGC is 1.21 USD — it has increased 4.31 % in the last trading day.

arrow icon

What is Canopy Growth Corp (CGC)'s business?

Canopy Growth Corporation is a Canada-based cannabis company. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. The Company delivers innovative products from owned and licensed brands, including Tweed, 7ACRES, DOJA, Deep Space, and Claybourne, as well as category defining vaporization devices by Storz & Bickel. Its segments include Canada cannabis, and Storz & Bickel. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. Its Storz & Bickel segment includes the production, distribution, and sale of vaporizers. In addition, it serves medical cannabis patients globally with principal operations in Canada, Europe and Australia.

arrow icon

What is the price predicton of CGC Stock?

Wall Street analysts forecast CGC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CGC is 5.70 USD with a low forecast of 5.70 USD and a high forecast of 5.70 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Canopy Growth Corp (CGC)'s revenue for the last quarter?

Canopy Growth Corp revenue for the last quarter amounts to 66.68M USD, increased 5.86 % YoY.

arrow icon

What is Canopy Growth Corp (CGC)'s earnings per share (EPS) for the last quarter?

Canopy Growth Corp. EPS for the last quarter amounts to -0.01 USD, decreased -99.32 % YoY.

arrow icon

What changes have occurred in the market's expectations for Canopy Growth Corp (CGC)'s fundamentals?

The market is revising Downward the revenue expectations for Canopy Growth Corporation (CGC) for FY2026, with the revenue forecasts being adjusted by -4.6% over the past three months. During the same period, the stock price has changed by -17.12%.
arrow icon

How many employees does Canopy Growth Corp (CGC). have?

Canopy Growth Corp (CGC) has 960 emplpoyees as of December 05 2025.

arrow icon

What is Canopy Growth Corp (CGC) market cap?

Today CGC has the market capitalization of 443.99M USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free